| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5455044 | PACIRA PHARMS INC | Method for treating neurological disorders |
May, 2013
(10 years ago) | |
| US5723147 | PACIRA PHARMS INC | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
Mar, 2015
(9 years ago) | |
Depocyt is owned by Pacira Pharms Inc.
Depocyt contains Cytarabine.
Depocyt has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Depocyt are:
- US5455044
- US5723147
Depocyt was authorised for market use on 01 April, 1999.
Depocyt is available in injectable, liposomal;injection dosage forms.
Depocyt can be used as intrathecal treatment of lymphomatous meningitis.
The generics of Depocyt are possible to be released after 03 March, 2015.
Drugs and Companies using CYTARABINE ingredient
Market Authorisation Date: 01 April, 1999
Treatment: Intrathecal treatment of lymphomatous meningitis
Dosage: INJECTABLE, LIPOSOMAL;INJECTION
More Information on Dosage
DEPOCYT family patents
